CC
CCEGF.US Carclo plc
- Market cap
- USD 48.5M
- P/E
- 22.0x
- P/B
- 2.18x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Mar 2026.
Is CCEGF.US undervalued?
Graham numberCCEGF.US trades 46.1% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Carclo plc fundamental analysis
No fundamental analysis for Carclo plc yet.
Carclo plc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Carclo plc
Carclo plc, together with its subsidiaries, operates as a plastics company in the United Kingdom, the rest of Europe, North America, and internationally. It operates in two segments, CTP and Speciality. The company offers in vitro diagnostics and medical devices, such as sample tips and probe tips, cuvettes and multi-well components, single-use cartridges and assay consumables, and ancillary parts for automation and fluid handling; and components and assemblies for a range o…
Full company profileCarclo plc financial statements
Carclo plc annual financial statements (GBP; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 138M | 146M | 105M | 111M | 108M | 129M | 143M | 133M | 121M | 115M |
| Gross Profit | 72.8M | 76.4M | 67.7M | 33.7M | 25.1M | 27.9M | 25.9M | 72.1M | 73.5M | 65.5M |
| Operating Income | 11.7M | 9.97M | 6.30M | 6.99M | 9.33M | 8.90M | 4.12M | 1.79M | 7.58M | 12.6M |
| EBITDA | 16.8M | 15.0M | 6.42M | 8.06M | 10.7M | 12.6M | 12.4M | 10.1M | 14.7M | 18.3M |
| Net Income | 8.00M | 8.49M | -2.94M | -1.90M | 7.41M | 5.80M | -3.96M | -3.30M | 872K | 2.70M |
| EPS | 0.12 | 0.12 | -0.04 | -0.03 | 0.10 | 0.08 | -0.05 | -0.04 | 0.01 | 0.04 |
| Balance Sheet | ||||||||||
| Total Assets | 160M | 160M | 150M | 119M | 116M | 128M | 123M | 101M | 97.0M | 92.6M |
| Total Liabilities | 115M | 108M | 137M | 110M | 108M | 104M | 111M | 97.3M | 109M | 101M |
| Shareholders' Equity | 44.3M | 52.0M | 12.3M | 8.76M | 7.94M | 24.4M | 11.6M | 3.69M | -11.8M | -8.67M |
| Cash & Short-term Investments | 22.3M | 13.0M | 10.3M | 19.3M | 15.5M | 12.3M | 10.4M | 5.97M | 10.7M | 5.78M |
| Total Debt | 48.3M | 44.4M | 48.8M | 46.7M | 43.1M | 44.8M | 44.7M | 39.9M | 29.9M | 29.8M |
| Cash Flow | ||||||||||
| Operating Cash Flow | 5.90M | 3.55M | 1.84M | 19.4M | 8.44M | 3.05M | 3.99M | 10.4M | 11.5M | 4.20M |
| Capital Expenditure | 7.86M | 8.77M | 6.90M | 8.53M | 7.32M | 4.94M | 2.42M | 2.94M | 1.10M | 2.53M |
| Free Cash Flow | -1.96M | -5.23M | -5.06M | 10.9M | 1.12M | -1.89M | 1.57M | 7.43M | 10.4M | 1.67M |
| Ratios | ||||||||||
| ROE | 18.1% | 16.3% | -23.9% | -21.7% | 93.4% | 23.7% | -34.0% | -89.5% | - | - |
| ROA | 5.0% | 5.3% | -2.0% | -1.6% | 6.4% | 4.5% | -3.2% | -3.3% | 0.9% | 2.9% |
| Net Profit Margin | 5.8% | 5.8% | -2.8% | -1.7% | 6.9% | 4.5% | -2.8% | -2.5% | 0.7% | 2.4% |
| Debt to Equity | 1.09x | 0.85x | 3.97x | 5.33x | 5.43x | 1.83x | 3.84x | 10.83x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Carclo plc dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Aug 25, 2016
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | - | - | - |
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
| 2019 | - | - | - |
| 2018 | USD 502K | 0.01 | 5.9% |
| 2017 | USD 596K | 0.01 | 7.5% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 5:1 on Sep 8, 1987.
Who owns Carclo plc
- Insiders 3.79%
- Institutions 33.45%
- Public & others 62.76%
- Shares outstanding 73.4M
- Free float 69.3M
Carclo plc company profile
- Company name
- Carclo plc
- Ticker
- CCEGF.US
- Exchange
- USA Stocks
- Sector
- Consumer Cyclical
- Industry
- Automobile Components
- Employees
- 907
- Fiscal year end
- March
- Address
- 47 Wates Way, Mitcham, United Kingdom, CR4 4HR
- Phone
- 44 20 8685 0500
- Website
- carclo.co.uk
About Carclo plc
Carclo plc, together with its subsidiaries, operates as a plastics company in the United Kingdom, the rest of Europe, North America, and internationally. It operates in two segments, CTP and Speciality. The company offers in vitro diagnostics and medical devices, such as sample tips and probe tips, cuvettes and multi-well components, single-use cartridges and assay consumables, and ancillary parts for automation and fluid handling; and components and assemblies for a range of drug delivery devices, including inhalers, auto-injectors and associated delivery systems. It also provides FusionCap, a vial closure concept; PureStop, a driving stopper engagement; GuardVial, a polymer vial; flight-control and low-stretch cables, streamline wires, and cable assembly and test; and CNC turning and milling, thread rolling, fixtures and small assemblies, and rapid specials for race programs. In addition, the company offers safety systems, arrestor gear ropes, inspection and life-cycle support, and rescue winch cables; and safety and security solutions. Carclo plc was incorporated in 1924 and is based in Mitcham, the United Kingdom.
Carclo plc management
5- Mr. Franciscus Lodewijk Paulus DoorenboschCEO & Executive Director · born 1964
- Mr. Ian Alan TichiasCFO, Company Secretary & Executive Director · born 1969
- Mr. Gary AllanChief Operating Officer
- Ms. Florentina AndronoviciHead of Legal
- Mr. Alan HookManaging Director of Bruntons